Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Biopharma Starts Clinical Trials on Possible Treatment for COVID-19
Details : The firm is using immunoglobulin, or antibodies made from the plasma cells of patients who have fully recovered from COVID-19
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
April 25, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable